Strumento inattivo

Pubblicazioni ufficiali CROSSJECT Euronext Paris

Azioni

Prezzo di chiusura Euronext Paris Altri mercati azionari
- ^EUR	-

10/07	Crossject ottiene un finanziamento pubblico di 7 milioni di euro per il nuovo prodotto Epinefrina	MT
10/07	Borsa di Italia: Mercati collegati alla corrente alternata

Monthly statement on voting rights	30/09/23	CO
1st-half-year results	26/09/23	CO
1st-half-year results	26/09/23	CO
Monthly statement on voting rights	31/08/23	CO
Monthly statement on voting rights	31/07/23	CO
Monthly statement on voting rights	30/06/23	CO
Minutes of the general assembly	07/06/23	CO
Changes in management and corporate officers	01/06/23	CO
Changes in management and corporate officers	01/06/23	CO
Monthly statement on voting rights	31/05/23	CO
Mixed general shareholder meeting	22/05/23	CO
Mixed general shareholder meeting	03/05/23	CO
Monthly statement on voting rights	30/04/23	CO
Annual Report	28/04/23	CO
Monthly statement on voting rights	31/03/23	CO
Annual results	20/03/23	CO
Annual results	20/03/23	CO
Provisional calendar	01/02/23	CO
Monthly statement on voting rights	31/01/23	CO
Monthly statement on voting rights	31/12/22	CO
Monthly statement on voting rights	30/11/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	30/11/22	CO
Monthly statement on voting rights	31/10/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	29/10/22	CO
Admission of new securities	26/10/22	CO